NIVOLUMAB (NIVO) MONOTHERAPY OR IN COMBINATION WITH IPILIMUMAB (IPI) FOR TREATMENT OF RECURRENT SMALL CELL LUNG CANCER (SCLC)
Publication
, Journal Article
Calvo, E; Lopez-Martin, J; Bendell, J; Eder, JP; Taylor, M; Ott, PA; Pietanza, MC; Horn, L; Jaeger, D; de Braud, F; Morse, MA; Ascierto, PA ...
Published in: Asia-Pacific Journal of Clinical Oncology
November 1, 2015
Duke Scholars
Published In
Asia-Pacific Journal of Clinical Oncology
EISSN
1743-7563
ISSN
1743-7555
Publication Date
November 1, 2015
Volume
11
Start / End Page
118 / 118
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Calvo, E., Lopez-Martin, J., Bendell, J., Eder, J. P., Taylor, M., Ott, P. A., … Antonia, S. J. (2015). NIVOLUMAB (NIVO) MONOTHERAPY OR IN COMBINATION WITH IPILIMUMAB (IPI) FOR TREATMENT OF RECURRENT SMALL CELL LUNG CANCER (SCLC). Asia-Pacific Journal of Clinical Oncology, 11, 118–118.
Calvo, Emiliano, Jose Lopez-Martin, Johanna Bendell, Joseph P. Eder, Matthew Taylor, Patrick A. Ott, M Catherine Pietanza, et al. “NIVOLUMAB (NIVO) MONOTHERAPY OR IN COMBINATION WITH IPILIMUMAB (IPI) FOR TREATMENT OF RECURRENT SMALL CELL LUNG CANCER (SCLC).” Asia-Pacific Journal of Clinical Oncology 11 (November 1, 2015): 118–118.
Calvo E, Lopez-Martin J, Bendell J, Eder JP, Taylor M, Ott PA, et al. NIVOLUMAB (NIVO) MONOTHERAPY OR IN COMBINATION WITH IPILIMUMAB (IPI) FOR TREATMENT OF RECURRENT SMALL CELL LUNG CANCER (SCLC). Asia-Pacific Journal of Clinical Oncology. 2015 Nov 1;11:118–118.
Calvo, Emiliano, et al. “NIVOLUMAB (NIVO) MONOTHERAPY OR IN COMBINATION WITH IPILIMUMAB (IPI) FOR TREATMENT OF RECURRENT SMALL CELL LUNG CANCER (SCLC).” Asia-Pacific Journal of Clinical Oncology, vol. 11, WILEY-BLACKWELL, Nov. 2015, pp. 118–118.
Calvo E, Lopez-Martin J, Bendell J, Eder JP, Taylor M, Ott PA, Pietanza MC, Horn L, Jaeger D, de Braud F, Morse MA, Ascierto PA, Le DT, Amin A, Evans J, Simon JS, Lin C-S, Christensen O, Antonia SJ. NIVOLUMAB (NIVO) MONOTHERAPY OR IN COMBINATION WITH IPILIMUMAB (IPI) FOR TREATMENT OF RECURRENT SMALL CELL LUNG CANCER (SCLC). Asia-Pacific Journal of Clinical Oncology. WILEY-BLACKWELL; 2015 Nov 1;11:118–118.
Published In
Asia-Pacific Journal of Clinical Oncology
EISSN
1743-7563
ISSN
1743-7555
Publication Date
November 1, 2015
Volume
11
Start / End Page
118 / 118
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis